Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY) Shares Shorted: Short Interest Up 1,048.7% in September

by · The Cerbat Gem

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLY – Get Free Report) was the recipient of a large growth in short interest in September. As of September 15th, there was short interest totaling 111,907 shares, a growth of 1,048.7% from the August 31st total of 9,742 shares. Based on an average daily trading volume, of 81,381 shares, the short-interest ratio is currently 1.4 days.

Ono Pharmaceutical Stock Performance

OTCMKTS:OPHLY traded down $0.13 during trading hours on Thursday, reaching $5.14. 57,185 shares of the company were exchanged, compared to its average volume of 35,325. The stock’s 50-day moving average is $5.04 and its 200-day moving average is $4.99. Ono Pharmaceutical has a twelve month low of $3.71 and a twelve month high of $5.75.

About Ono Pharmaceutical

(Get Free Report)

Ono Pharmaceutical Co, Ltd. is a Japan-based research-driven pharmaceutical company that discovers, develops, manufactures and markets prescription medicines. Its principal focus areas include oncology, immunology, neurology and other specialty diseases, with an emphasis on innovative treatments for conditions with significant unmet medical needs.

The company is best known internationally for Opdivo (nivolumab), an immune checkpoint inhibitor developed in collaboration with Bristol Myers Squibb and used in the treatment of multiple types of cancer.

See Also